Progress towards the integration of pharmacogenomics in practice
- PMID:25238897
- PMCID: PMC4362928
- DOI: 10.1007/s00439-014-1484-7
Progress towards the integration of pharmacogenomics in practice
Abstract
Understanding the role genes and genetic variants play in clinical treatment response continues to be an active area of research with the goal of common clinical use. This goal has developed into today's industry of pharmacogenomics, where new drug-gene relationships are discovered and further characterized, published and then curated into national and international resources for use by researchers and clinicians. These efforts have given us insight into what a pharmacogenomic variant is, and how it differs from human disease variants and common polymorphisms. While publications continue to reveal pharmacogenomic relationships between genes and specific classes of drugs, many challenges remain toward the goal of widespread use clinically. First, the clinical guidelines for pharmacogenomic testing are still in their infancy. Second, sequencing technologies are changing rapidly making it somewhat unclear what genetic data will be available to the clinician at the time of care. Finally, what and when to return data to a patient is an area under constant debate. New innovations such as PheWAS approaches and whole genome sequencing studies are enabling a tsunami of new findings. In this review, pharmacogenomic variants, pharmacogenomic resources, interpretation clinical guidelines and challenges, such as WGS approaches, and the impact of pharmacogenomics on drug development and regulatory approval are reviewed.
Similar articles
- Pharmacogenomics and bioinformatics: PharmGKB.Thorn CF, Klein TE, Altman RB.Thorn CF, et al.Pharmacogenomics. 2010 Apr;11(4):501-5. doi: 10.2217/pgs.10.15.Pharmacogenomics. 2010.PMID:20350130Free PMC article.
- Institutional Profile: Pharmacogenomic research in R Stephanie Huang Laboratory.Geeleher P, Nath A, Huang RS.Geeleher P, et al.Pharmacogenomics. 2017 Apr;18(6):519-522. doi: 10.2217/pgs-2017-0031. Epub 2017 Mar 14.Pharmacogenomics. 2017.PMID:28290771
- Web resources for pharmacogenomics.Zhang G, Zhang Y, Ling Y, Jia J.Zhang G, et al.Genomics Proteomics Bioinformatics. 2015 Feb;13(1):51-4. doi: 10.1016/j.gpb.2015.01.002. Epub 2015 Feb 19.Genomics Proteomics Bioinformatics. 2015.PMID:25703229Free PMC article.Review.
- Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.Arbitrio M, Scionti F, Di Martino MT, Caracciolo D, Pensabene L, Tassone P, Tagliaferri P.Arbitrio M, et al.Clin Transl Sci. 2021 Jan;14(1):113-119. doi: 10.1111/cts.12869. Epub 2020 Oct 22.Clin Transl Sci. 2021.PMID:33089968Free PMC article.Review.
- Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text.Garten Y, Altman RB.Garten Y, et al.BMC Bioinformatics. 2009 Feb 5;10 Suppl 2(Suppl 2):S6. doi: 10.1186/1471-2105-10-S2-S6.BMC Bioinformatics. 2009.PMID:19208194Free PMC article.
Cited by
- Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine.Maagdenberg H, Vijverberg SJ, Bierings MB, Carleton BC, Arets HG, de Boer A, Maitland-van der Zee AH.Maagdenberg H, et al.Paediatr Drugs. 2016 Aug;18(4):251-60. doi: 10.1007/s40272-016-0176-2.Paediatr Drugs. 2016.PMID:27142473Free PMC article.Review.
- Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.Roosan D, Hwang A, Roosan MR.Roosan D, et al.Pharmacogenomics J. 2021 Feb;21(1):1-7. doi: 10.1038/s41397-020-00182-9. Epub 2020 Aug 25.Pharmacogenomics J. 2021.PMID:32843688Free PMC article.Review.
- Clinical application and importance of one-step human CYP2C19 genotype detection.Zheng LJ, Liu N, Yang K, Wang AF, Tan ZR, Li X.Zheng LJ, et al.J Int Med Res. 2018 Dec;46(12):4965-4973. doi: 10.1177/0300060518787718. Epub 2018 Oct 25.J Int Med Res. 2018.PMID:30360673Free PMC article.
- Pharmacogenomics: A Step forward Precision Medicine in Childhood Asthma.Ferrante G, Fasola S, Malizia V, Licari A, Cilluffo G, Piacentini G, La Grutta S.Ferrante G, et al.Genes (Basel). 2022 Mar 28;13(4):599. doi: 10.3390/genes13040599.Genes (Basel). 2022.PMID:35456405Free PMC article.Review.
- Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide.Tsermpini EE, Al-Mahayri ZN, Ali BR, Patrinos GP.Tsermpini EE, et al.Hum Genet. 2022 Jun;141(6):1137-1157. doi: 10.1007/s00439-021-02369-x. Epub 2021 Oct 1.Hum Genet. 2022.PMID:34599365Review.
References
- (FDA) T. F. a. D. A Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling. 2013 fromhttp://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati....
- Allison M. Genetic testing clamp down. Nat Biotechnol. 2010;28(7):633. - PubMed
- Ardlie KG, Kruglyak L, Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet. 2002;3(4):299–309. - PubMed
- Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, Altman RB. Clinical assessment incorporating a personal genome. Lancet. 2010;375(9725):1525–1535. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources